Neuropathy due to toxicity (Q49112): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Ao considerar o diagnóstico de neuropatia tóxica, dois critérios devem ser atendidos: (1) A exposição pode ser verificada e temporariamente relacionada ao início dos sintomas clínicos. Os sintomas neuropáticos geralmente ocorrem simultaneamente com a exposição ou após uma latência variável de até vários meses. (2) Deve haver sinais neurológicos e estudos eletrodiagnósticos anormais, porque muitas neuropatias tóxicas são subclínicas, os sintomas subjetivos podem ou não ocorrer. A remoção da exposição resulta na cessação da progressão dos sintomas e do déficit. A maioria das toxinas produz degeneração axonal simétrica em um padrão comprimento-dependente, começando nos segmentos distais das fibras nervosas longas e de grande calibre, eventualmente se espalhando proximalmente com a exposição contínua. Além dos déficits motores e / ou sensitivos, a dor intensa pode ser um aspecto característico. | |||||||||||||||
| description / en | description / en | ||||||||||||||
In considering the diagnosis of toxic neuropathy, two criteria should be met: (1) Exposure can be verified and temporally related to the onset of clinical symptoms. Neuropathic symptoms usually occur concurrently with the exposure or following a variable latency of up to several months. (2) There must be neurological signs and abnormal electrodiagnostic studies, because many toxic neuropathies are subclinical, subjective symptoms may or may not occur. Removal from exposure results in cessation of progression of symptoms and the deficit. Most toxins produce symmetrical axonal degeneration in a length-dependent pattern, beginning in the distal segments of the long and large-calibre nerve fibres eventually spreading proximally with continued exposure. In addition to motor and/or sensory deficits, severe pain may be a characteristic feature. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1851919630 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:8D43.2 | |||||||||||||||
| Property / CURIE: CID11:8D43.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-8D43.2 | |||||||||||||||
| Property / Canary Token: dki-india-8D43.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: T65.9 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 19:23, 13 August 2026
In considering the diagnosis of toxic neuropathy, two criteria should be met: (1) Exposure can be verified and temporally related to the onset of clinical symptoms. Neuropathic symptoms usually occur concurrently with the exposure or following a variable latency of up to several months. (2) There must be neurological signs and abnormal electrodiagnostic studies, because many toxic neuropathies are subclinical, subjective symptoms may or may not occur. Removal from exposure results in cessation of progression of symptoms and the deficit. Most toxins produce symmetrical axonal degeneration in a length-dependent pattern, beginning in the distal segments of the long and large-calibre nerve fibres eventually spreading proximally with continued exposure. In addition to motor and/or sensory deficits, severe pain may be a characteristic feature.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 8D43.2 |
||
| English | Neuropathy due to toxicity |
In considering the diagnosis of toxic neuropathy, two criteria should be met: (1) Exposure can be verified and temporally related to the onset of clinical symptoms. Neuropathic symptoms usually occur concurrently with the exposure or following a variable latency of up to several months. (2) There must be neurological signs and abnormal electrodiagnostic studies, because many toxic neuropathies are subclinical, subjective symptoms may or may not occur. Removal from exposure results in cessation of progression of symptoms and the deficit. Most toxins produce symmetrical axonal degeneration in a length-dependent pattern, beginning in the distal segments of the long and large-calibre nerve fibres eventually spreading proximally with continued exposure. In addition to motor and/or sensory deficits, severe pain may be a characteristic feature. |
Statements
CID11:8D43.2
0 references
dki-india-8D43.2
0 references
Concluído
0 references
13 August 2026
0 references
